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As for many other adult stem cells, the behavior of hematopoietic stem and progenitor
cells (HSPCs) is subjected to circadian regulatory patterns. Multiple HSPC functions,
such as proliferation, differentiation or trafficking exhibit time-dependent patterns that
require a tight coordination to ensure daily blood cell production. The autonomic
nervous system, together with circulating hormones, relay circadian signals from the
central clock—the suprachiasmatic nucleus in the brain—to synchronize HSC niche
physiology according to light/darkness cycles. Research over the last 20 years has
revealed how specific neural signals modulate certain aspects of circadian HSC biology.
However, only recently some studies have started to decipher the cellular and molecular
mechanisms that orchestrate this complex regulation in a time-dependent fashion. Here
we firstly review some of the recent key findings illustrating how different neural signals
(catecholaminergic or cholinergic) regulate circadian HSC egress, homing, maintenance,
proliferation, and differentiation. In particular, we highlight the critical role of different
neurotransmitter receptors in the bonemarrowmicroenvironment to channel these neural
signals and regulate antagonistic processes according to circadian cues and organismal
demands. Then, we discuss the potential biological meaning of HSC circadian regulation
and its possible utility for clinical purposes. Finally, we offer our perspective on emerging
concepts in HSC chronobiology.
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INTRODUCTION
Throughout evolution, most species have developed the capacity to adapt their behavior
and physiology to the day-night oscillations derived from earth’s 24 h rotation. In
mammals, these so-called circadian functions are synchronized by light-darkness shifts,
and influenced by other factors, such as alimentary habits. The circadian system has
at least two different levels of complexity. Centrally, the suprachiasmatic nucleus,
located in the hypothalamus, is the anatomical structure that orchestrates the organism’s
circadian activities. This master clock receives photic input from photosensitive neurons
in the retina through the retino-hypothalamic tract and processes this information to
synchronize the circadian rhythms in peripheral tissues. However, most cells display at
least one intrinsic or internal clock that influences their proliferation, differentiation and
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migration properties. This cellular clock is periodically reset
by neuroendocrine signals emanating from the suprachiasmatic
nucleus, which resets or synchronizes the peripheral oscillators
throughout the body (1).
Already in the late 70s it was suspected that circadian
rhythms might decisively influence stem cell functions and thus
control both homeostasis and regeneration of peripheral tissues
(2). Hematopoietic stem cells (HSCs) stand out as one of the
most studied stem cell types. HSC functions are subjected to
circadian fluctuations to ensure blood cell replenishment in
mice and humans (3, 4). Although several studies have reported
the expression of circadian clock genes (such as Bmal1, Clock,
Cry1, Cry2, Per1, Per2, Rev-erb alpha, and Rev-erb beta) in
mouse or human HSCs (5, 6), these genes do not exhibit clear
light/darkness oscillatory patterns in HSCs (7). Indeed, a two-
clock timing model was proposed to explain these differences in
clock genes regulation (8). This model distinguishes between an
endogenous clock, which is dominant in the neural system and is
adjusted daily by photic signals, and an exogenous clock, which
is more relevant for hemato-immune cells and is synchronized
by environmental factors and/or changes in the organismal
metabolism. According to this model, circadian rhythms in blood
cells would be mostly regulated by the exogenous clock and
rely on other oscillatory metabolic parameters and external cues
(light-independent). However, as explained with more detail
in the following sections, extensive research over the last few
decades has demonstrated that photic cues and neural signals
indeed regulate important circadian HSC functions in the bone
marrow (BM) microenvironment.
The sympathetic branch of the autonomic nervous system
connects the master clock in the central nervous system with
peripheral organs to relay circadian information. For instance,
adrenergic signals regulate clock gene expression in mouse liver
(9), mouse heart (10), mouse and human osteoblasts (11, 12)
and mouse brown adipose tissue (13). Similarly, β2-adrenergic
receptor appears to regulate clock gene expression in BM stromal
cells (14). Whilst adrenergic activity contributes to synchronize
the peripheral oscillator, peripheral circadian rhythmicity can be
maintained through other unknown mechanisms in the absence
of adrenergic signaling (15).
Sympathetic nerves enter the BM associated with arteries
and arterioles, and once inside the BM these nerves sprout
throughout the BM space. BM sympathetic fibers mainly
release noradrenaline in the BM, although both circulating
noradrenaline and adrenaline can also reach the BM cavity via
the vascular network (16). In sharp contrast, there is scarce
neuroanatomical evidence of parasympathetic innervation in
the BM. Although an indirect parasympathetic regulation of
sympathetic postganglionary terminals cannot be excluded, the
lack of parasympathetic fibers in the BM probably explains
the scarce evidence for cholinergic regulation in the BM. It is
important to note that not all autonomic cholinergic fibers are
parasympathetic. In fact, some sympathetic fibers innervating
the sweat glands or the periosteum undergo a neurotransmitter
switch during postnatal development and start releasing
acetylcholine (17, 18). Until recently, the role of these so-called
sympathetic cholinergic nerve fibers in the BM has remained
elusive. We have recently found that bone-associated cholinergic
fibers play a crucial role in day/night oscillations of circulating
HSCs and leukocytes. Indeed, sympathetic cholinergic fibers
cooperate with the previously known sympathetic noradrenergic
fibers and with central parasympathetic signals to orchestrate the
circadian migration of HSCs and leukocytes between the BM and
the bloodstream (19).
In this article, we discuss recent findings clarifying the roles
of (nor)adrenergic and cholinergic signals to regulate different
circadian HSC functions in BM niches. The future directions
and perceived challenges for the future development of this
multisystemic research are outlined below.
NEURAL REGULATION OF CIRCADIAN
HSC TRAFFIC
The HSC is a unique type of adult stem cell since it preserves a
remarkable migratory capacity at adulthood (20). HSCs circulate
between the BM and the bloodstream in response to chemotactic
signals, among which the C-X-C motif chemokine 12 (CXCL12)
stands out as the most important chemokine. Although the
biological function of HSC traffic is not yet fully understood,
it is now accepted that HSCs circulate following circadian
oscillations controlled by neural signals in different species,
including humans (21, 22).
In the mouse system, sympathetic postganglionic terminals
convey the circadian information from the suprachiasmatic
nucleus to the BM, where noradrenaline is locally released.
The adrenergic signals activate β3-adrenergic receptors in BM
nestin+mesenchymal stem cells (MSCs) and modulate CXCL12
production. This regulation leads to daily fluctuations in BM
CXCL12 levels that inversely correlate with HSC numbers in
the bloodstream. At daytime (the resting period in mice), light-
induced noradrenergic signals downregulate CXCL12 expression
via Sp1 transcription factor and promote HSC egress to the
bloodstream. At night, BM CXCL12 levels are restored and
HSCs preferentially return to the BM (also referred to as “HSC
homing”). Remarkably, although circadian signals reach the BM
through sympathetic terminals, their origin is set in the clock
genes of the suprachiasmatic nucleus since normal circadian
fluctuations are entrained by light and disappear in Bmal1−/−
mice (21). Importantly, the expression of the CXCL12 receptor
CXCR4 in HSPCs is also subjected to circadian oscillations
synchronized with the ligand. In the human system, these
circadian oscillations are also detected but inverted compared
with mice, as expected from humans and mice respectively
being diurnal and nocturnal species (22). Interestingly, mouse
and human circulating leukocytes also exhibit opposite circadian
oscillations when they coexist in humanized mice (23),
suggesting that cell-autonomous mechanisms are involved in
species-specific circadian regulation.
Different types of adrenergic receptors cooperate in the
regulation of HSC traffic. Besides the described role for β3-
adrenergic receptor, β2-adrenergic receptor appears to regulate
clock gene expression in BM stromal cells and cooperates
with β3-adrenergic receptor in HSPC mobilization induced
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by granulocyte colony-stimulating factor (G-CSF), the agent
most commonly used in the clinics (14). Interestingly, the
same β-adrenergic receptor signaling was proposed to govern
circadian leukocyte recruitment to mouse tissues (including
the BM) during the nocturnal (active) phase in mice through
stimulation of vascular endothelial cell adhesion (24). Therefore,
these studies underscore the role of sympathetic noradrenergic
signals as master regulators of circadian migration of leukocytes
and HSCs/progenitors, which overall follow similar patterns.
Daily neutrophil clearance by macrophages could be one event
synchronizing leukocyte and HSPC trafficking. Macrophages are
key cells to maintain HSCs in the BM (25, 26). Using mouse
models, Casanova-Acebes et al. showed that aged neutrophils
migrate at the end of the resting period to the BM, where they
are engulfed by macrophages. This leads to the activation of LXR
nuclear receptors on macrophages, which reduces the capacity of
MSCs to retain HSPCs in the BM (27).
Despite these important findings, some critical aspects of
circadian hematopoietic stem and progenitor cell (HSPC) traffic
have long remained unanswered. For instance, A) how do BM
stromal cells integrate similar noradrenergic signals at different
circadian times and yet trigger distinct migratory processes
(egress vs. homing)? In contrast to BM stroma-restricted
expression of β3-adrenergic receptor, β2-adrenergic receptor
is ubiquitously expressed (28, 29). As mentioned before, β2-
adrenergic receptor cooperates with β3-adrenergic receptor in G-
CSF-induced HSPC mobilization (14). Interestingly, adrenaline
and noradrenaline can bind to β2-and β3-adrenergic receptors
but they do so with very different affinities (30), suggesting
that adrenaline and noradrenaline could have different effects
on various cell types depending on the repertoire of adrenergic
receptors expressed by the target cells. B) In that regard,
do sympathetic neurotransmitters elicit similar responses if
they signal in different BM cell populations or even through
different β-adrenergic receptors in the same cell? C) Is
noradrenaline the only neurotransmitter controlling circadian
HSPC traffic?
An additional candidate neurotransmitter regulating HSPC
traffic was hypothesized to be acetylcholine. Although modest,
cholinergic innervation arising from the cholinergic forebrain
and brain stem nuclei has been found in the suprachiasmatic
nucleus. These cholinergic neurons have been proposed to
play a role in the formation of time memory (memory of a
specific time of the day associated with a certain event) (31).
Recently, it was revealed that these cholinergic signals promote
G-CSF-induced HSC mobilization from the BM through a
glucocorticoid-signaling relay (32). Circulating glucocorticoids,
such as corticosterone, follow circadian oscillations in blood
and control HSPC proliferation through Notch signaling (33)
and T cell distribution and activity through IL-7 receptor
and CXCR4 (34). However, the precise role of circulating
catecholamines in the circadian regulation of BMHSC niches was
not well-understood.
In the context of physiological human hematopoietic cell
trafficking between the BM and peripheral blood, one group
of leukocytes (granulocytes, macrophages, natural killer cells,
extrathymic T cells, gamma delta T cells and CD8+ cells) peak
in the bloodstream at daytime, whilst another group (CD4+ T
cells and B cells) exhibit an increase at night. Interestingly, those
leukocytes with peak numbers in circulation at daytime express
a higher density of adrenergic receptors, whereas those peaking
at night carry a higher proportion of cholinergic receptors
(35). Together, these data suggest a potential role for both
adrenergic and cholinergic systems in the regulation of circadian
hematopoietic cell trafficking.
Indeed, we recently showed that the autonomic cholinergic
nervous system (including parasympathetic nerves but also a
proportion of sympathetic neurons releasing acetylcholine)
cooperates with (nor)adrenergic sympathetic signals to
orchestrate day/night oscillations of circulating HSPCs and
leukocytes (19). Our findings reveal a dual cholinergic signaling
that plays different roles in mice at day and night (Figure 1).
At night, inhibitory central cholinergic signals
(parasympathetic) dampen sympathetic noradrenergic tone
to reduce nocturnal egress of HSPCs and leukocytes from
the BM into bloodstream. Whether central parasympathetic
circadian activity is regulated by core clock genes in the
suprachiasmatic nucleus or elsewhere remains unknown.
Collectively, the results suggest that this cholinergic
regulation cooperates with adrenergic signaling to drive
HSPC and leukocytes recruitment to the BM during the
active phase (night for rodents, day for humans). We
propose that plasma adrenaline, which follows circadian
fluctuations peaking at night (36, 37), preferentially binds
to β2-adrenergic receptors to promote vascular adhesion
and BM homing at night. Supporting this possibility, BM
mRNA expression of β2- and β3-adrenergic receptors
oscillate peaking at night or day, respectively, and genetic
or pharmacological blockade of each receptor demonstrated
their circadian time-dependent roles in HSC or leukocyte BM
egress/homing (19).
In mice, light cues trigger sympathetic noradrenergic activity,
which signals through β3-adrenergic receptor leading to
predominant BM egress of HSPCs and leukocytes in the morning
(21). However, light exposure seems to equally activate a subset
of bone-associated sympathetic cholinergic neurons (18), whose
functions had remained elusive. Our data show that light-
triggered sympathetic cholinergic signals inhibit BM vascular
cell adhesion and homing, which enable predominant egress
of HSPCs and leukocytes into bloodstream at this circadian
time (19).
Selective predominance of different β-adrenergic signaling
at daytime and night, together with differential affinities of
catecholamines for β-adrenergic receptors, may explain how
sympathetic noradrenergic signals trigger BM egress or homing
at different time points. Furthermore, we propose that a
robust circadian rhythmicity in β-adrenergic receptor expression
in BM stromal cells allows for these fine-tuned oscillations.
Whereas, β3-adrenergic receptor expression is higher after light
exposure (when BM egress becomes overriding), β2-adrenergic
receptor expression predominates at night (when BM homing is
maximum) (19). An additional role for sympathetic cholinergic
innervation in this circadian regulation appears to be the
inhibition of β3-adrenergic receptor expression at night.
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FIGURE 1 | The “circadian clock” for HSPCs. HSPC biology is subjected to light-entrained circadian regulation orchestrated by the central clock (suprachiasmatic
nucleus in the brain) and relayed to the BM by neural signals (noradrenergic and cholinergic), hormones and cytokines. At daytime (left panel), these signals trigger
mouse HSPC proliferation, differentiation and egress to the bloodstream. At night (right panel), similar signals trigger different responses in the BM microenvironment
resulting in mouse HSPC quiescence, self-renewal and homing to BM or peripheral tissues. In humans (diurnal), circadian oscillations occur in antiphase with mice
(nocturnal). Therefore, the HSPC harvest yield from peripheral blood would be higher during the evening, whereas the homing efficiency of the transplanted HSPCs
would be higher in the morning in humans. Although the possible role of clock genes in HSPCs remains under-investigated and might not be essential under
homeostasis, clock genes (which regulate cell cycle) in HSCs might be important during stress or in hematological malignancies.
NEURAL REGULATION OF CIRCADIAN
HSC PROLIFERATION
Whilst it has been long appreciated that mouse and human
HSPC proliferation (indirectly measured as DNA synthesis in
the BM) follows a cyclic pattern, whether it is subjected to a
bona-fide circadian rhythmicity has remained controversial for
a long time (38–45). A potential role of the nervous system in
this regulation was suggested after finding circadian fluctuations
of catecholamines in human blood (46). Importantly, a
pioneering study from Maestroni and colleagues had shown
that noradrenergic stimulation promotes BM proliferation and
protects against carboplatin-induced chemotherapy (47), which
was later confirmed at the HSC level (48). Along these lines,
noradrenaline concentration in themouse BM correlates with the
proportion of cycling hematopoietic cells (both peaking during
the night or active phase for rodents), which altogether suggested
that neural signals transduce the circadian information from the
brain to the BM (16, 49). These observations also helped to
understand the circadian-related differences in the capacity of
murine HSPC to engraft in immunodeficient mice (50).
The Lapidot group confirmed these initial findings in
humans using immature CD34+ cells (51). It is important
to note that human and mouse hematopoietic cells appear
to have a different clockwork, since inverted oscillations of
circulating leukocytes have been described in immunodeficient
mice carrying human and mouse leukocytes (52). Interspecies
differences of stress-kinase regulation of reactive oxygen species
(ROS), hypoxia-inducible factor 1α (HIF-1α) and clock gene–
dependent regulation of the CXCL12 receptor CXCR4 appear to
explain the opposite migratory patterns for human and mouse
leukocytes (23). Noradrenaline and dopamine were found to
increase human HSPC motility, proliferation, colony formation
capacity and engraftment into immunodeficient mice (51).
Interestingly, some neurotransmitters (such as noradrenaline)
can exert these functions through directly activating β2-
adrenergic receptors on hematopoietic cells (51). Therefore, the
sympathetic nervous system regulates HSPC function through
concerted actions on different receptors expressed by HSPCs (51)
and their niche cells (19, 21).
The Lapidot laboratory has recently revealed the role
of circadian BM noradrenergic signals in regulating the
maintenance, proliferation and differentiation of mouse HSCs
(53). Interestingly, two daily peaks of BM HSPC activity (one
diurnal, one nocturnal) are preceded by transient increases of
noradrenaline and tumor necrosis factor (TNF). Resembling
circadian HSC traffic regulation through the BM niche (19,
21), the same signal appears to trigger different responses
at each circadian time. For instance, TNF in the morning
promotes HSPC proliferation, differentiation and migration,
whilst TNF burst at night induces melatonin secretion to
increase HSPC maintenance and self-renewal (53) (Figure 1).
Overall, sympathetic noradrenergic signals cooperate with TNF
levels to orchestrate blood cell replenishment during the
day, whilst they serve to maintain the BM HSPC pool at
night. The noradrenaline-TNF pathway promotes opposite
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HSC functions through a combination of mechanistic players
including differential regulation of reactive oxygen species,
vascular permeability, antigen expression and macrophage
function. Based on the important contribution of the cholinergic
neural system to day/night oscillations in HSPC and leukocyte
migration (19), the possible regulation of HSPC proliferation and
differentiation by cholinergic signals will be studied in the future.
A BIOLOGICAL MEANING FOR CIRCADIAN
HSC REGULATION
The idiosyncrasy of the central master clock inmammals suggests
that the biological benefit of these circadian oscillations might
reside in its capacity to integrate and orchestrate different
physiological functions that require precise coordination in order
to adapt to organismal demands. The bone organ (including
bone and BM) might actually represent a paradigmatic example
of integrated physiology (54), since research over the past
few decades has shown that bone and BM are coordinately
regulated. For instance, whilst β3-adrenergic receptor was
originally described to control circadian HSC traffic between
the BM and the bloodstream, β2-adrenergic receptor has a
prominent role in the circadian proliferation of bone-forming
osteoblasts (11). Sequential proliferation and differentiation
of MSC and osteolineage cells occurs at distinct circadian
times. In rodents, preosteoblasts, the immediate proliferating
precursors of osteoblasts, synthesize DNA primarily during the
light cycle and divide during the subsequent dark cycle, whereas
more immature osteoprogenitors display an inverted cycle (55).
Perivascular nestin+ MSC are in contact with sympathetic
fibers and are targeted by sympathetic efferent activity, whereas
preosteoblasts are distributed closer to the bone surface (56). In
addition, β3-adrenoceptor activation in nestin+ MSC inhibits
their osteoblastic differentiation, while it does not affect their
proliferation (56). In BM stromal cells, like osteoblasts, β2-
adrenoceptor stimulation induces clock gene expression, whereas
activation of β3-adrenoceptor downregulates Cxcl12 (14). These
data, together with the increased proliferation of nestin+
MSC after chemical sympathectomy (56), suggests that β2-
adrenoceptor activation is responsible for circadian induction
of nestin+ MSC proliferation, like previously reported for
preosteoblasts (11). Therefore, it is possible that the differential
localization, innervation and expression of β-adrenoceptors
allow for circadian coordinated regulation of proliferation and
differentiation of preosteoblasts and MSC, the last directly
affecting HSC maintenance in the BM.
More broadly, many cytokines regulating bone accrual and
bone formation work in a circadian fashion (with higher bone
formation rate during the day in rodents) (57, 58). Therefore,
since both systems are closely associated and even share multiple
cell types and molecular pathways, it is reasonable to hypothesize
that their circadian regulation is a control mechanism to ensure
the coordinated and homeostatic function of the bone organ as
a whole.
Alternatively, it has been proposed that daily HSC egress to
circulation during the resting phase (light in rodents and night
in humans) might contribute to regenerate BM stem cell niches
(22, 59). Circulating HSCs would migrate to extramedullary
tissues, where they could differentiate into mature hematopoietic
cell types (60). It is important to note that the number of
circulating HSCs at any time is very low, hampering the
demonstration of their biological function. Furthermore, it is
difficult to separate the impact of circadian rhythms per se from
the physiological processes undergoing oscillations. For instance,
sleep deprivation in mice reduces by 50% the capacity of HSCs
to engraft into recipient mice undergoing normal day/night
sleep cycles (61), but it is difficult to discern the effects of
altered biological oscillations from the lack of regeneration due
to sleep deprivation.
Another possible function of circadian HSPC traffic would
be to maintain a pool of circulating progenitor cells to
anticipate potential requirements derived from stress situations.
In this sense, inflammatory monocytes have been found
to follow circadian oscillations. However, this was shown
to be mediated by intrinsic Bmal1 expression in myeloid
cells, rather than light or environmental cues (62). In the
aging context, some adult stem cells such as epidermal,
muscle or liver stem cells do not lose their core circadian
machinery, but their transcriptome switches from homeostasis
genes to tissue-specific stress genes (e.g., DNA damage or
autophagy) to adapt to age-related traits (63, 64). Supporting
this idea, we found an adrenergic signaling switch in the aged
BM niches from predominant β3- to β2-adrenergic receptor
signaling, which facilitates myeloid cell expansion during
aging (65).
As indicated above, clock genes in HSCs do not seem to play
a crucial role in the homeostatic regulation of healthy HSCs
but, as gatekeeper regulators of cell cycle, they can acquire a
prominent role during stress (e.g., cancer, inflammation, etc.)
(66). In contrast to healthy HSCs, the expansion of leukemic
stem cells seems to be highly dependent on core clock genes.
Bmal1 and Clock transcription factors were reportedly essential
for leukemic stem cell self-renewal in acute myeloid leukemia
(66). Therefore, anti-carcinogenic chronotherapies might take
advantage of this susceptibility factor to target cancer stem
cells without affecting normal stem cells. Furthermore, BM
neuropathy is critical for the development of myeloproliferative
neoplasms and acute myelogenous leukemia (67, 68), whilst
altered noradrenergic signaling has been reported in aging (65,
69). Since neural signals are subjected to circadian fluctuations in
the healthy/homeostatic BM, the disruption of neural circadian
regulation might also contribute to disease/aging development,
and thus represent a niche-related target for chronotherapies.
In general, chronotherapy approaches in cancer have proven
much more difficult than expected probably due to the interplay
of different clocks and multiple entrainment signals in humans
as a cause of notorious heterogeneity (52). It is important
to note that the clock genes comprise only one of several
cellular clocks. Other studies have found clock gene–independent
mechanisms that maintain circadian cycles. For instance, ROS-
regulating enzymes, such as peroxiredoxins, are ancient clocks
that have been conserved throughout evolution (70). Therefore,
future efforts in chronotherapy should take into account the
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interplay between the genetic clock and metabolic clocks,
for instance.
POTENTIAL CLINICAL IMPLICATIONS OF
CIRCADIAN HSC RHYTHMS
Since both circadian HSC proliferation and migration can
impact HSC numbers in circulation, on a practical note it
is recommended that clinicians consider harvesting blood
(apheresis) later during the day to increase the stem cell
yield in cases where HSC numbers might be limiting for
the success of HSC transplantation procedures. Based on
experimental evidence, a 2-3-fold higher HSPC number
can be harvested by apheresis in the evening, compared
with the morning apheresis, even after G-CSF-enforced
HSC mobilization (22, 71). In contrast, it is expected that
human HSC homing and subsequent engraftment in the BM
would be more efficient early in the morning, when the BM
transplantation procedure would be recommended for “poor
engrafters” (24).
CONCLUSIONS AND PERSPECTIVES
In this article, we have summarized our current knowledge of
the circadian regulation of HSPCs with a particular focus on
the important yet intriguing role of sympathetic noradrenergic
signals promoting HSPC proliferation, differentiation and egress
during the resting phase (daytime for rodents), and HSPC
maintenance, self-renewal and BM homing during the active
phase (night for rodents) (Figure 1). The concerted regulation
of HSPC function by noradrenergic signals requires fine-
tuned control of adrenergic receptor expression, cytokines
(e.g., TNF), hormones (like adrenaline or melatonin), ROS,
vascular adhesion and permeability and, more broadly, BM HSC
niche cells, such as MSCs, endothelial cells and macrophages.
Moreover, the noradrenergic sympathetic system does act alone
but cooperates daily with peripheral sympathetic cholinergic
fibers and with central parasympathetic tone to orchestrate
this complex HSPC regulation (19). A fascinating interplay
among different organs takes place between brain, bone
and BM to ensure that each organ’s response meets the
organismal demands.
The pathophysiological implications of the internal HSC
clock remain largely unknown. In other systems, like the
epidermis, the molecular clock machinery underlies the
heterogeneity in the epidermal stem cell pool and could
directly impact cell fate decisions, such as proliferation vs.
dormancy. Particularly, differential clock gene expression
leads to distinct responses of epidermal stem cells to
transforming growth factor (TGF)-β and Wnt, which are
signals that normally sustain their quiescence or proliferation,
respectively (72). Furthermore, single-cell technology has
revealed clock gene-dependent metabolic oscillations
coordinated with DNA synthesis in these proliferating
stem cells (73). It is possible that some of these regulatory
mechanisms of epidermal stem cells are shared with HSCs,
but this remains to be investigated. By the same token,
the principles of neural regulation of HSC niches might
be extrapolated in the future to other tissues, including
the epidermis.
Whilst the influence of the neural system on HSPC
differentiation has already been noted (53), the molecular drivers
of cell commitment deserve further investigation. Likewise,
cross-fertilization of ideas with other stem cell systems might
pave the way for candidate molecular pathways involved. For
instance, in both mouse and human embryonic stem cells,
the in vitro pluripotent potential inversely correlates with
the establishment of a circadian clock machinery, suggesting
a function of the clock genes during embryonic stem cell
differentiation (74, 75). Comparatively, the differentiating
signals possibly driving the emergence of the clock core
genes in adult stem cells are poorly understood (76). The
potential role of neural signals either triggering and/or
entraining clock-dependent differentiation of HSCs remains to
be investigated.
Finally, cumulative evidence points toward the interplay
among circadian clock system disruption, stress situations
and multiple systemic diseases (77). In the hematopoietic
field, unraveling the contribution of neural signals to HSC
circadian regulation under acute or chronic stress might help
to develop novel chronobiological therapies for hematological
disorders based on neuroactive agents. As Hippocrates quoted:
“Healing is a matter of time, but it is sometimes also a matter
of opportunity.”
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